{"id":"https://openalex.org/W2587948128","doi":"https://doi.org/10.1093/annonc/mdw377.20","title":"Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries","display_name":"Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries","alternate_titles":[],"publication_year":2016,"publication_date":"2016-10-01","ids":{"openalex":"https://openalex.org/W2587948128","doi":"https://doi.org/10.1093/annonc/mdw377.20","mag":"2587948128"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdw377.20","doi":"https://doi.org/10.1093/annonc/mdw377.20","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdw377.20","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2587948128"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1093/annonc/mdw377.20","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032293637","display_name":"Lesley G Shane","orcid":"https://orcid.org/0009-0007-3204-5720","observed_orcids":["https://orcid.org/0009-0007-3204-5720"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Shane","raw_affiliation_strings":["Global Health and Value, Pfizer Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health and Value, Pfizer Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078386925","display_name":"George Dranitsaris","orcid":"https://orcid.org/0000-0002-1637-3122","observed_orcids":["https://orcid.org/0000-0002-1637-3122"]},"institutions":[{"id":"https://openalex.org/I4210128961","display_name":"Augmentium Pharma Consulting (Canada)","ror":"https://ror.org/032vq8n85","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210128961"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"G. Dranitsaris","raw_affiliation_strings":["Outcomes Research, Augmentium Pharma Consulting Inc, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Outcomes Research, Augmentium Pharma Consulting Inc, Toronto, ON, Canada","institution_ids":["https://openalex.org/I4210128961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036100354","display_name":"Seth Woodruff","orcid":"https://orcid.org/0000-0002-9355-0348","observed_orcids":["https://orcid.org/0000-0002-9355-0348"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Woodruff","raw_affiliation_strings":["Medical, Pfizer Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical, Pfizer Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004629712","display_name":"J.\u2010P. Galanaud","orcid":"https://orcid.org/0000-0003-2705-3615","observed_orcids":["https://orcid.org/0000-0003-2705-3615"]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.-P. Galanaud","raw_affiliation_strings":["Department of Internal Medicine, Montpellier University Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Montpellier University Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082779314","display_name":"Gunar Stemer","orcid":"https://orcid.org/0000-0001-9647-315X","observed_orcids":["https://orcid.org/0000-0001-9647-315X"]},"institutions":[{"id":"https://openalex.org/I2802328216","display_name":"Vienna General Hospital","ror":"https://ror.org/05f0zr486","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I2802328216"]},{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"G. Stemer","raw_affiliation_strings":["Pharmacy, Vienna General Hospital (AKH) - Medizinische Universit\u00e4t Wien, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy, Vienna General Hospital (AKH) - Medizinische Universit\u00e4t Wien, Vienna, Austria","institution_ids":["https://openalex.org/I2802328216","https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051507920","display_name":"P. Debourdeau","orcid":"https://orcid.org/0000-0003-3761-9264","observed_orcids":["https://orcid.org/0000-0003-3761-9264"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Debourdeau","raw_affiliation_strings":["Oncology, Hopital Desgenettes, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Hopital Desgenettes, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042828460","display_name":"B. Valtier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118061","display_name":"Pfizer (France)","ror":"https://ror.org/02c9yny10","country_code":"FR","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210118061"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Valtier","raw_affiliation_strings":["Medical, Pfizer France, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical, Pfizer France, Paris, France","institution_ids":["https://openalex.org/I4210118061"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113561820","display_name":"L.T. Burgers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122616","display_name":"Pfizer (Netherlands)","ror":"https://ror.org/02bzf1224","country_code":"NL","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210122616"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"L. Burgers","raw_affiliation_strings":["Public Affairs and Policy, Pfizer BV, Capelle aan den Ijssel, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Affairs and Policy, Pfizer BV, Capelle aan den Ijssel, Netherlands","institution_ids":["https://openalex.org/I4210122616"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":null,"first_page":"vi356","last_page":"vi356"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.01730000041425228,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dalteparin","display_name":"dalteparin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vitamin-k-antagonists","display_name":"vitamin K antagonists","score":0.9829999804496765},{"id":"https://openalex.org/keywords/recurrent-venous-thromboembolism","display_name":"recurrent venous thromboembolism","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.7749999761581421},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.9290000200271606},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.7260000109672546},{"id":"https://openalex.org/keywords/cost-per-qaly","display_name":"cost per QALY","score":0.7730000019073486},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8190000057220459},{"id":"https://openalex.org/keywords/resource-utilization-health-care","display_name":"resource utilization (health care)","score":0.7020000219345093},{"id":"https://openalex.org/keywords/health-utility","display_name":"health utility","score":0.6589999794960022},{"id":"https://openalex.org/keywords/time-trade-off","display_name":"time trade-off","score":0.7670000195503235},{"id":"https://openalex.org/keywords/preference-assessment","display_name":"preference assessment","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9520593881607056},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5229483246803284},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4548507332801819},{"id":"https://openalex.org/C515549039","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost-effectiveness analysis","level":3,"score":0.4536359906196594},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.45282962918281555},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.4490965008735657},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4313048720359802},{"id":"https://openalex.org/C2776704044","wikidata":"https://www.wikidata.org/wiki/Q2852541","display_name":"Vitamin K antagonist","level":4,"score":0.4200237989425659},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41544950008392334},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.41466179490089417},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.3604090213775635},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.1993507444858551},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.12993678450584412},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.12031671404838562},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdw377.20","doi":"https://doi.org/10.1093/annonc/mdw377.20","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdw377.20","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdw377.20","doi":"https://doi.org/10.1093/annonc/mdw377.20","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdw377.20","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2891767026","https://openalex.org/W2570534554","https://openalex.org/W2395194296","https://openalex.org/W2502651801","https://openalex.org/W2587903894","https://openalex.org/W2019655913","https://openalex.org/W2460097838","https://openalex.org/W4241359667","https://openalex.org/W2810237727","https://openalex.org/W2261497345"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2587948128","counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-02-24T00:00:00"}
